An advisory committee to the Food and Drug Administration (FDA) is recommending approval of lofexidine, which would offer an alternative to opioid medications for treatment of opioid withdrawal symptoms.
An advisory committee to the Food and Drug Administration (FDA) is recommending approval of lofexidine, which would offer an alternative to opioid medications for treatment of opioid withdrawal symptoms.
An advisory committee to the...